Global project to map drug resistance and tackle “superbugs” is launched
BMJ 2017; 359 doi: https://doi.org/10.1136/bmj.j4769 (Published 13 October 2017) Cite this as: BMJ 2017;359:j4769- Jacqui Wise
- London
A project that aims to generate the largest dataset on antimicrobial resistance has been launched as part of a global effort to tackle the growing problem of drug resistant “superbugs.”
The Global Burden of Disease AMR project is a collaboration between the UK government, the UK health research charity the Wellcome Trust, the Bill and Melinda Gates Foundation, the University of Oxford, and the Institute for Health Metrics and Evaluation, an independent research centre at the University of Washington, Seattle.
Over the next four years the project will gather and publish data on the spread and effects of antimicrobial resistance around the world.
England’s chief medical …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.